Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000407867

Medchemexpress LLC Ketorolac | 74103-06-3 | 50 MG
SDP

Catalog No. 5000407867
Encompass_Preferred

Ketorolac (Standard) is the analytical standard of Ketorolac. It is a non-steroidal anti-inflammatory drug (NSAID) that acts as a nonselective COX inhibitor. It has IC50s of 20 nM for COX-1 and 120 nM for COX-2. Ketorolac tromethamine is used in a 0.5% ophthalmic solution for research into allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation and pain. Additionally, Ketorolac tromethamine is a DDX3 inhibitor and has potential for cancer research.

  • Analytical standard for Ketorolac
  • Non-steroidal anti-inflammatory drug (NSAID)
  • Acts as a nonselective COX inhibitor
  • Potential for research into allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation and pain
  • Functions as a DDX3 inhibitor with potential for cancer research
  • Intended for research and analytical applications

Catalog No. 50-004-07867 Supplier Medchemexpress LLC Supplier No. HYB0580R50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ketorolac (Standard) is the analytical standard of Ketorolac. It is a non-steroidal anti-inflammatory drug (NSAID) that acts as a nonselective COX inhibitor. It has IC50s of 20 nM for COX-1 and 120 nM for COX-2. Ketorolac tromethamine is used in a 0.5% ophthalmic solution for research into allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation and pain. Additionally, Ketorolac tromethamine is a DDX3 inhibitor and has potential for cancer research.

  • Analytical standard for Ketorolac
  • Non-steroidal anti-inflammatory drug (NSAID)
  • Acts as a nonselective COX inhibitor
  • Potential for research into allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation and pain
  • Functions as a DDX3 inhibitor with potential for cancer research
  • Intended for research and analytical applications

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.